Aaron M. Bender
Vanderbilt University
H-index: 13
North America-United States
Top articles of Aaron M. Bender
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists | ACS Medicinal Chemistry Letters | Navoda Jayakodiarachchi Mallory A Maurer Daniel C Schultz Cayden J Dodd Analisa Thompson Gray | 2024/1/19 |
Antagonists of the muscarinic acetylcholine receptor m4 | 2023/11/21 | ||
Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4 | 2023/6/15 | ||
Positive allosteric modulators of the muscarinic acetylcholine receptor M1 | 2023/12/26 | ||
Identification of potent, selective, and peripherally restricted serotonin receptor 2B antagonists from a high-throughput screen | ASSAY and Drug Development Technologies | Aaron M Bender Michael S Valentine Joshua A Bauer Emily Days Craig W Lindsley | 2023/4/1 |
DARK classics in chemical neuroscience: methaqualone | Joseph A Inger Elias R Mihan Jhansi U Kolli Craig W Lindsley Aaron M Bender | 2023/1/18 | |
Development of a selective and high affinity radioligand,[3H] VU6013720, for the M4 muscarinic receptor | Molecular Pharmacology | Aidong Qi Haley E Kling Natasha Billard Alice L Rodriguez Li Peng | 2023/11/1 |
Alkylation of N H-sulfoximines under Mitsunobu-type conditions | Organic & Biomolecular Chemistry | Cayden J Dodd Daniel C Schultz Jinming Li Craig W Lindsley Aaron M Bender | 2023 |
Development of a Peripherally Restricted 5-HT2B Partial Agonist for Treatment of Pulmonary Arterial Hypertension | Basic to Translational Science | Michael S Valentine Aaron M Bender Sheila Shay Krista C Paffenroth Santhi Gladson | 2023/10/1 |
2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery | Aaron M Bender Lauren C Parr William B Livingston Craig W Lindsley W David Merryman | 2023/8/16 | |
Synthesis and characterization of chiral 6-azaspiro [2.5] octanes as potent and selective antagonists of the M4 muscarinic acetylcholine receptor | Bioorganic & Medicinal Chemistry Letters | Aaron M Bender Trever R Carter Matthew Spock Alice L Rodriguez Jonathan W Dickerson | 2022/1/15 |
Development of Novel M4 Muscarinic Acetylcholine Receptor Antagonists for the Treatment of Movement Disorders | The FASEB Journal | Jerri Rook Aaron Bender Jonathan Dickerson Daniel Foster Alice Rodriguez | 2022/5 |
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1 | Bioorganic & medicinal chemistry letters | Paul K Spearing Hyekyung P Cho Vincent B Luscombe Anna L Blobaum Olivier Boutaud | 2021/9/1 |
Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist | ACS Medicinal Chemistry Letters | Matthew Spock Trever R Carter Katrina A Bollinger Changho Han Logan A Baker | 2021/8/2 |
Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy | ACS Pharmacology & Translational Science | Mark S Moehle Aaron M Bender Jonathan W Dickerson Daniel J Foster Aidong Qi | 2021/8/2 |
MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4 | 2021/5/12 | ||
DARK classics in chemical neuroscience: carfentanil | Anna E Ringuette Matthew Spock Craig W Lindsley Aaron M Bender | 2020/8/11 | |
Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | 2020/7/14 | ||
Synthesis of Substituted 6,7-Dihydro-5H-pyrrolo[2,3-c]pyridazines/pyrazines via Catalyst-Free Tandem Hydroamination–Aromatic Substitution | The Journal of Organic Chemistry | Jeremy A Turkett Anna E Ringuette Craig W Lindsley Aaron M Bender | 2020/3/31 |
